Tokyo, Japan

Shuichi Yokohama

This inventor holds 7 USPTO granted patents. Top assignees: Daiichi Pharmaceutical Co., Ltd., Daiichi Seiyaku Co., Ltd.. Active years: 1989-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuichi Yokohama. Retrieved from https://idiyas.com/inventor/shuichi-yokohama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1989-1999

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Shuichi Yokohama: Innovator in Pharmaceutical Chemistry

Introduction

Shuichi Yokohama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work focuses on developing innovative compounds with enhanced properties.

Latest Patents

Yokohama's latest patents include advancements in aminophenol derivatives and optically active pyridobenzoxazine derivatives. These inventions disclose a process for preparing optically active pyridobenzoxazine derivatives, which possess increased antimicrobial activity and reduced toxicity. The intermediates developed are useful for preparing optically active pyridobenzoxazine derivatives such as Ofloxacin and analogous compounds.

Career Highlights

Throughout his career, Shuichi Yokohama has worked with notable companies, including Daiichi Pharmaceutical Co., Ltd. and Daiichi Seiyaku Co., Ltd. His expertise in pharmaceutical chemistry has led to significant advancements in drug development and formulation.

Collaborations

Yokohama has collaborated with esteemed colleagues, including Isao Hayakawa and Shohgo Atarashi. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Shuichi Yokohama's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of effective pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…